Common use of Research Milestones Clause in Contracts

Research Milestones. (a) As additional consideration for Institute entering into this Agreement and diligently progressing the activities under the Research Collaboration in accordance with this Agreement, Atara has paid, or will pay to Institute the research milestone payments (each, a “Research Milestone Payment”) set forth in the table below for each Allogeneic CTL Product and/or Autologous CTL Product (as applicable pursuant to the table set forth below) to achieve the corresponding milestone (each, a “Research Milestone”), whether achieved by Institute, Atara or an Affiliate or sublicensee of Atara. The Party achieving such Research Milestone shall promptly notify the other Party in writing of the achievement of any such Research Milestone and Atara shall pay Institute in full the corresponding Research Milestone Payment within [***] of such achievement. For clarity, each Research Milestone Payment is payable once only for each Allogeneic CTL Product and once for each Autologous CTL Product, and each Research Milestone Payment is non-refundable, and is not an advance against royalties due to Institute or any other amounts due to Institute. The Parties acknowledge and agree that as of the Execution Date, Xxxxx has paid the Research Milestone Payment for First Dosing in a Human Subject for a CTL Product Specifically Directed to EBV for a first Allogeneic CTL Product. Research Milestone Trigger Event Research Milestone Payment CTL Product Specifically Directed [***] Licensed Product Arising Directly From Activities under New Research Programs [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] *Milestone payable only once with respect to each Allogeneic Licensed Product to achieve such Milestone. **Milestone payable once for each Allogeneic CTL Product and for each Autologous CTL Product to achieve such Research Milestone.

Research Milestones. (a) As additional consideration for Institute entering into this Agreement and diligently progressing the activities under the Research Collaboration in accordance with this Agreement, Atara has paid, or will pay to Institute the research milestone payments (each, a “Research Milestone Payment”) set forth in the table below for each Allogeneic CTL Product and/or Autologous CTL Product (as applicable pursuant to the table set forth below) to achieve the corresponding milestone (each, a “Research Milestone”), whether achieved by Institute, Atara or an Affiliate or sublicensee of Atara. The Party achieving such Research Milestone shall promptly notify the other Party in writing of the achievement of any such Research Milestone and Atara shall pay Institute in full the corresponding Research Milestone Payment within [***[ * ] of such achievement. For clarity, each Research Milestone Payment is payable once only for each Allogeneic CTL Product and once for each Autologous CTL Product, and each Research Milestone Payment is non-refundable, and is not an advance against royalties due to Institute or any other amounts due to Institute. The Parties acknowledge and agree that as of the Execution Date, Xxxxx Atara has paid the Research Milestone Payment for First Dosing in a Human Subject for a CTL Product Specifically Directed to EBV for a first Allogeneic CTL Product. Research Milestone Trigger Event Research Milestone Payment CTL Product Specifically Directed [***to [ * ] Licensed Product Arising Directly From Activities under New Research Programs [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] *Milestone payable only once with respect to each Allogeneic Licensed Product to achieve such Milestone. [*]= Certain confidential information contained in this document, marked by brackets, is omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. **Milestone payable once for each Allogeneic CTL Product and for each Autologous CTL Product to achieve such Research Milestone.

Research Milestones. (a) As additional consideration for Institute entering into this Agreement and diligently progressing the activities under the Research Collaboration in accordance with this Agreement, Atara has paid, or will pay to Institute the research milestone payments (each, a “Research Milestone Payment”) set forth in the table below for each Allogeneic CTL Product and/or Autologous CTL Product (as applicable pursuant to the table set forth below) to achieve the corresponding milestone (each, a “Research Milestone”), whether achieved by Institute, Atara or an Affiliate or sublicensee of Atara. The Party achieving such Research Milestone shall promptly notify the other Party in writing of the achievement of any such Research Milestone and Atara shall pay Institute in full the corresponding Research Milestone Payment within [***] of such achievement. For clarity, each Research Milestone Payment is payable once only for each Allogeneic CTL Product and once for each Autologous CTL Product, and each Research Milestone Payment is non-refundable, and is not an advance against royalties due to Institute or any other amounts due to Institute. The Parties acknowledge and agree that as of the Execution Date, Xxxxx Atara has paid the Research Milestone Payment for First Dosing in a Human Subject for a CTL Product Specifically Directed to EBV for a first Allogeneic CTL Product. 9746176_1.docx Research Milestone Trigger Event Research Milestone Payment CTL Product Specifically Directed to [***] Licensed Product Arising Directly From Activities under New Research Programs [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] *Milestone payable only once with respect to each Allogeneic Licensed Product to achieve such Milestone. **Milestone payable once for each Allogeneic CTL Product and for each Autologous CTL Product to achieve such Research Milestone.

Research Milestones. (a) As additional consideration for Institute entering into this Agreement and diligently progressing the activities under the Research Collaboration in accordance with this Agreement, Atara has paid, or will pay to Institute the research milestone payments (each, a “Research Milestone Payment”) set forth in the table below for each Allogeneic CTL Product and/or Autologous CTL Product (as applicable pursuant to the table set forth below) to achieve the corresponding milestone (each, a “Research Milestone”), whether achieved by Institute, Atara or an Affiliate or sublicensee of Atara. The Party achieving such Research Milestone shall promptly notify the other Party in writing of the achievement of any such Research Milestone and Atara shall pay Institute in full the corresponding Research Milestone Payment within [***[ * ] of such achievement. For clarity, each Research Milestone Payment is payable once only for each Allogeneic CTL Product and once for each Autologous CTL Product, and each Research Milestone Payment is non-refundable, and is not an advance against royalties due to Institute or any other amounts due to Institute. The Parties acknowledge [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and agree that as filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Execution DateSecurities Exchange Act of 1934, Xxxxx has paid the Research Milestone Payment for First Dosing in a Human Subject for a CTL Product Specifically Directed to EBV for a first Allogeneic CTL Productas amended. Research Milestone Trigger Event Research Milestone Payment CTL Product Specifically Directed [***to [ * ] CTL Product Specifically Directed to [ * ] Licensed Product Arising Directly From Activities under New Research Programs [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [***[ * ] [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] *Milestone payable only once with respect to each Allogeneic Licensed Product to achieve such Milestone. **Milestone payable once for each Allogeneic CTL Product and for each Autologous CTL Product to achieve such Research Milestone.